Nuclear survivin expression predicts poorer prognosis in glioblastoma

Journal of Neuro-Oncology

Volumn 91, Issue 3, 2009, Pages 353-358

  Shirai, Katsuyuki ^a   Suzuki, Yoshiyuki ^a,c   Oka, Kuniyuki ^b   Noda, Shin Ei ^a   Katoh, Hiroyuki ^a   Suzuki, Yoshihiko ^c   Itoh, Jun ^d   Itoh, Hideaki ^d   Ishiuchi, Shogo ^a   Sakurai, Hideyuki ^a   Hasegawa, Masatoshi ^a   Nakano, Takashi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Mito Saiseikai General Hospital   (Japan)

^c National Hospital Organization   (Japan)

^d MAEBASHI RED CROSS HOSPITAL   (Japan)

Author keywords

Cytoplasm; Glioblastoma; Nuclear; Radiotherapy; Survivin

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; SURVIVIN;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; CELL NUCLEUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; RADIOTHERAPY; TIME FACTORS;

EID: 58149468632     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9720-4     Document Type: Article

References (44)

1. Li F, Ambrosini G, Chu EY et al (1998) Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580-584. doi: 10.1038/25141
2. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-921. doi: 10.1038/nm0897-917
3. Tamm I, Wang Y, Sausville E et al (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58:5315-5320
4. Shariat SF, Lotan Y, Saboorian H et al (2004) Survivin expression is associated with features of biologically aggressive prostate carcinoma. Cancer 100:751-757. doi: 10.1002/cncr.20039
5. Kawasaki H, Altieri DC, Lu CD et al (1998) Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58:5071-5074
6. Kami K, Doi R, Koizumi M et al (2004) Survivin expression is a prognostic marker in pancreatic cancer patients. Surgery 136:443-448. doi: 10.1016/j.surg.2004.05.023
7. Shinohara ET, Gonzalez A, Massion PP et al (2005) Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma. Cancer 103:1685-1692. doi: 10.1002/cncr.20951
8. Lu B, Gonzalez A, Massion PP et al (2004) Nuclear survivin as a biomarker for non-small-cell lung cancer. Br J Cancer 91:537-540. doi: 10.1038/sj.bjc.6602027
9. Okada E, Murai Y, Matsui K et al (2001) Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett 163:109-116. doi: 10.1016/S0304-3835(00)00677-7
10. Lehner R, Lucia MS, Jarboe EA et al (2002) Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma. Appl Immunohistochem Mol Morphol 10:134-138. doi: 10.1097/00022744-200206000-00007
11. Kennedy SM, O'Driscoll L, Purcell R et al (2003) Prognostic importance of survivin in breast cancer. Br J Cancer 88:1077-1083. doi: 10.1038/ sj.bjc.6600776
12. Trieb K, Lehner R, Stulnig T et al (2003) Survivin expression in human osteosarcoma is a marker for survival. Eur J Surg Oncol 29:379-382. doi: 10.1053/ejso.2002.1415
13. Chakravarti A, Noll E, Black PM et al (2002) Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol 20:1063-1068. doi: 10.1200/JCO.20.4.1063
14. Kleihues P, Burger PC, Scheithauer BW (1993) Histological typing of tumours of the central nervous system. World Health Organization international histological classification of tumours, 2nd edn. Springer-Verlag, Berlin
15. Sasaki T, Lopes MB, Hankins GR et al (2002) Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system. Acta Neuropathol 104:105-109. doi: 10.1007/s00401-002-0532-x
16. Kajiwara Y, Yamasaki F, Hama S et al (2003) Expression of survivin in astrocytic tumors correlation with malignant grade and prognosis. Cancer 97:1077-1083. doi: 10.1002/cncr.11122
17. Saito T, Arifin MT, Hama S et al (2007) Survivin subcellular localization in high-grade astrocytomas: Simultaneous expression in both nucleus and cytoplasm is negative prognostic marker. J Neurooncol 82:193-198. doi: 10.1007/s11060-006-9267-1
18. Uematsu M, Ohsawa I, Aokage T et al (2005) Prognostic significance of the immunohistochemical index of survivin in glioma: A comparative study with the MIB-1 index. J Neurooncol 72:231-238. doi: 10.1007/ s11060-004-2353-3
19. Das A, Tan WL, Teo J et al (2002) Expression of survivin in primary glioblastomas. J Cancer Res Clin Oncol 128:302-306. doi: 10.1007/ s00432-002-0343-4
20. Xie D, Zeng YX, Wang HJ et al (2006) Expression of cytoplasmic and nuclear survivin in primary and secondary human glioblastoma. Br J Cancer 94:108-114. doi: 10.1038/sj.bjc.6602904
21. Preusser M, Gelpi E, Matej R et al (2005) No prognostic impact of survivin expression in glioblastoma. Acta Neuropathol 109:534-538. doi: 10.1007/s00401-005-0992-x
22. Mellai M, Caldera V, Patrucco A et al (2008) Survivin expression in glioblastomas correlates with proliferation, but not with apoptosis. Anticancer Res 28:109-118
23. Fortugno P, Wall NR, Giodini A et al (2002) Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J Cell Sci 115:575-585
24. Uren AG, Wong L, Pakusch M et al (2000) Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol 10:1319-1328. doi: 10.1016/ S0960-9822(00)00769-7
25. Rodel F, Hoffmann J, Distel L et al (2005) Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res 65:4881-4887. doi: 10.1158/0008-5472.CAN-04-3028
26. Grabowski P, Kuhnel T, Muhr-Wilkenshoff F et al (2003) Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer 88:115-119. doi: 10.1038/sj.bjc.6600696
27. Sarela AI, Macadam RC, Farmery SM et al (2000) Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut 46:645-650. doi: 10.1136/gut.46.5.645
28. Kappler M, Kotzsch M, Bartel F et al (2003) Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival. Clin Cancer Res 9:1098-1104
29. Span PN, Sweep FC, Wiegerinck ET et al (2004) Survivin is an independent prognostic marker for risk stratification of breast cancer patients. Clin Chem 50:1986-1993. doi: 10.1373/clinchem.2004.039149
30. Pizem J, Cor A, Gale N (2004) Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation. Histopathology 45:180-186. doi: 10.1111/ j.1365-2559.2004.01925.x
31. Ito T, Shiraki K, Sugimoto K et al (2000) Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology 31:1080-1085. doi: 10.1053/he.2000.6496
32. Cohen C, Lohmann CM, Cotsonis G et al (2003) Survivin expression in ovarian carcinoma: Correlation with apoptotic markers and prognosis. Mod Pathol 16:574-583. doi: 10.1097/01.MP.0000073868.31297.B0
33. Mahotka C, Liebmann J, Wenzel M et al (2002) Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ 9:1334-1342. doi: 10.1038/sj.cdd.4401091
34. Mahotka C, Wenzel M, Springer E et al (1999) Survivin-deltaEx3 and survivin-2B: Two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res 59:6097-6102
35. Yamada Y, Kuroiwa T, Nakagawa T et al (2003) Transcriptional expression of survivin and its splice variants in brain tumors in humans. J Neurosurg 99:738-745
36. O'Connor DS, Wall NR, Porter AC et al (2002) A p34cdc2 survival checkpoint in cancer. Cancer Cell 2:43-54. doi: 10.1016/ S1535-6108(02)00084-3
37. Islam A, Kageyama H, Hashizume K et al (2000) Role of survivin, whose gene is mapped to 17q25, in human neuroblastoma and identification of a novel dominant-negative isoform, survivin-beta/2B. Med Pediatr Oncol 35:550-553. doi:10.1002/ 1096-911X(20001201)35:6<550::AID-MPO12>3.0.CO;2-Y
38. Lo ML, Pannone G, Staibano S et al (2003) Survivin expression in oral squamous cell carcinoma. Br J Cancer 89:2244-2248. doi: 10.1038/ sj.bjc.6601402
39. Suzuki Y, Oka T, Yoshida D et al (2006) Correlation between survivin expression and prognosis in cervical squamous cell carcinomas treated with radiation therapy. Gynecol Oncol 104:642-646. doi: 10.1016/ j.ygyno.2006.10.005
40. Yang L, Cao Z, Yan H et al (2003) Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: Implication for cancer specific therapy. Cancer Res 63:6815-6824
41. Ansell SM, Arendt BK, Grote DM et al (2004) Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma. Leukemia 18:616-623. doi: 10.1038/sj.leu.2403281
42. Van Houdt WJ, Haviv YS, Lu B et al (2006) The human survivin promoter: A novel transcriptional targeting strategy for treatment of glioma. J Neurosurg 104:583-592. doi: 10.3171/jns.2006.104.4.583
43. Chakravarti A, Zhai GG, Zhang M et al (2004) Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. Oncogene 23:7494-7506. doi: 10.1038/sj.onc.1208049
44. Saito T, Hama S, Izumi H et al (2008) Centrosome amplification induced by survivin suppression enhances both chromosome instability and radiosensitivity in glioma cells. Br J Cancer 98:345-355. doi: 10.1038/ sj.bjc.6604160